Developed by the Chinese laboratories CanSino Biologics, the Convidecia vaccine was urgently approved by the WHO, this Thursday, May 19.
The World Health Organization (WHO) announced on Thursday that it approved “emergency” the vaccine invited, developed by Chinese laboratories. A validation that comes as China has been fighting against an upsurge in Covid cases for several weeks, especially in its capital Beijing, more recently.
The Convidecia vaccine uses the technique of modified human adenovirus and can be administered in a single dose. The WHO recommends its use for adults over 18 years of age.
It’s about 9e WHO approved covid vaccine since the start of the pandemic.
A controversial “0 Covid” strategy
To deal with an upsurge in cases, the Chinese government did not hesitate to enforce containment “ultra-strict” in the metropolis of Shanghai from 1is April, even if it means attracting the wrath of the locals. Nevertheless, the metropolis of 25 million inhabitants recorded his fifth consecutive day without a new infectionmaintaining its “zero COVID” status and maintaining the hope of an imminent end to the confinement period.
As for the capital, Beijing has not imposed strict confinement, but gradually tightened restrictions to contain a limited but persistent outbreak of a few dozen new infections per day. It reported 55 new cases on May 18, up from 69 previously.